Literature DB >> 34078960

Isotonic quadriceps endurance is better associated with daily physical activity than quadriceps strength and power in COPD: an international multicentre cross-sectional trial.

Erik Frykholm1, Sarah Gephine2,3, Didier Saey2, Arthur Lemson4, Peter Klijn5,6, Eline Bij de Vaate5, François Maltais2, Hieronymus van Hees4, André Nyberg7.   

Abstract

Knowledge about modifiable determinants of daily physical activity (PA) in patients with chronic obstructive pulmonary disease (COPD) is crucial to design effective PA interventions. The present study aimed to determine the contribution of quadriceps strength, power and endurance to daily PA in COPD. Additionally, for quadriceps endurance, we also aimed to determine to what extent the association varies according to the mode of movement (isotonic, isometric, or isokinetic). Using a multicentre cross-sectional trial design we determined the contribution of quadriceps function to daily PA (steps, sedentary time and time spent doing moderate-to-very-vigorous physical activity [MVPA]) using bivariate and partial Pearson correlation analysis (r) and multiple linear regression models (ΔR2). Pre-determined controlling factors were sex, age, body mass index (BMI), COPD-assessment test, forced expiratory volume in one second in percent of the predicted value (FEV1pred), and distance walked on the 6-minute walk test. Eighty-one patients with COPD (mean ± SD: age 67 ± 8 years, FEV1pred 57 ± 19%, daily steps 4968 ± 3319, daily sedentary time 1016 ± 305 min, and MVPA time 83 ± 45 min) were included. Small to moderate bivariate correlations (r = .225 to .452, p < .05) were found between quadriceps function and measures of PA. The best multiple linear regression models explained 38-49% of the variance in the data. Isotonic endurance was the only muscle contributor that improved all PA models; daily steps (ΔR2 = .04 [relative improvement 13%] p = .026), daily sedentary time (ΔR2 = .07 [23%], p = .005) and MVPA-minutes (ΔR2 = .08 [20%], p = .001). Isotonic endurance was also independently associated with most PA variables, even when controlling for strength, power or isometric-isokinetic endurance properties of the muscle (r = .246 to .384, p < .05). In contrast, neither strength, power, isometric-or isokinetic endurance properties of the muscle was independently associated with PA measures when controlling for isotonic endurance (r = .037 to .219, p > .05). To conclude, strength, power, and endurance properties of the quadriceps were low to moderately associated with PA in patients with COPD. Isotonic quadriceps endurance was the only quadriceps property that was independently associated with the different measures of PA after controlling for a basic set of known determinants of PA, quadriceps strength or power, or isometric or isokinetic quadriceps endurance. Future longitudinal studies should investigate its potential as a modifiable determinant of PA.

Entities:  

Year:  2021        PMID: 34078960     DOI: 10.1038/s41598-021-90758-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  42 in total

Review 1.  Changes in structural and metabolic muscle characteristics following exercise-based interventions in patients with COPD: a systematic review.

Authors:  Jana De Brandt; Martijn A Spruit; Wim Derave; Dominique Hansen; Lowie E G W Vanfleteren; Chris Burtin
Journal:  Expert Rev Respir Med       Date:  2016-04-06       Impact factor: 3.772

2.  Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study.

Authors:  Benjamin Waschki; Anne Kirsten; Olaf Holz; Kai-Christian Müller; Thorsten Meyer; Henrik Watz; Helgo Magnussen
Journal:  Chest       Date:  2011-01-27       Impact factor: 9.410

Review 3.  Is quadriceps endurance reduced in COPD?: a systematic review.

Authors:  Rachael A Evans; Eric Kaplovitch; Marla K Beauchamp; Thomas E Dolmage; Roger S Goldstein; Clare L Gillies; Dina Brooks; Sunita Mathur
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

4.  Changes in physical activity and all-cause mortality in COPD.

Authors:  Anouk W Vaes; Judith Garcia-Aymerich; Jacob L Marott; Marta Benet; Miriam T J Groenen; Peter Schnohr; Frits M E Franssen; Jørgen Vestbo; Emiel F M Wouters; Peter Lange; Martijn A Spruit
Journal:  Eur Respir J       Date:  2014-07-25       Impact factor: 16.671

Review 5.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

Review 6.  Level of daily physical activity in individuals with COPD compared with healthy controls.

Authors:  Sigrid N W Vorrink; Helianthe S M Kort; Thierry Troosters; Jan-Willem J Lammers
Journal:  Respir Res       Date:  2011-03-22

7.  An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.

Authors:  Martijn A Spruit; Sally J Singh; Chris Garvey; Richard ZuWallack; Linda Nici; Carolyn Rochester; Kylie Hill; Anne E Holland; Suzanne C Lareau; William D-C Man; Fabio Pitta; Louise Sewell; Jonathan Raskin; Jean Bourbeau; Rebecca Crouch; Frits M E Franssen; Richard Casaburi; Jan H Vercoulen; Ioannis Vogiatzis; Rik Gosselink; Enrico M Clini; Tanja W Effing; François Maltais; Job van der Palen; Thierry Troosters; Daisy J A Janssen; Eileen Collins; Judith Garcia-Aymerich; Dina Brooks; Bonnie F Fahy; Milo A Puhan; Martine Hoogendoorn; Rachel Garrod; Annemie M W J Schols; Brian Carlin; Roberto Benzo; Paula Meek; Mike Morgan; Maureen P M H Rutten-van Mölken; Andrew L Ries; Barry Make; Roger S Goldstein; Claire A Dowson; Jan L Brozek; Claudio F Donner; Emiel F M Wouters
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

8.  Predictive factors over time of health-related quality of life in COPD patients.

Authors:  Cristóbal Esteban; Inmaculada Arostegui; Amaia Aramburu; Javier Moraza; Josu Najera-Zuloaga; Myriam Aburto; Susana Aizpiri; Leyre Chasco; José M Quintana
Journal:  Respir Res       Date:  2020-06-05

9.  Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD).

Authors:  Angela T Burge; Narelle S Cox; Michael J Abramson; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2020-04-16

Review 10.  Determinants and outcomes of physical activity in patients with COPD: a systematic review.

Authors:  Elena Gimeno-Santos; Anja Frei; Claudia Steurer-Stey; Jordi de Batlle; Roberto A Rabinovich; Yogini Raste; Nicholas S Hopkinson; Michael I Polkey; Hans van Remoortel; Thierry Troosters; Karoly Kulich; Niklas Karlsson; Milo A Puhan; Judith Garcia-Aymerich
Journal:  Thorax       Date:  2014-02-20       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.